IRME.US International Display Advertising Inc
- Market cap
- USD 231K
- P/E
- -
- P/B
- 66.26x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2025.
Is IRME.US undervalued?
Graham numberThe Graham number of International Display Advertising Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
International Display Advertising Inc fundamental analysis
No fundamental analysis for International Display Advertising Inc yet.
International Display Advertising Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About International Display Advertising Inc
IR-Med Inc., a medical device company, engages in the development of non-invasive devices for various medical indications. The company's development products pipeline consists of PressureSafe, a handheld skin-agnostic optical monitoring device that supports early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; DiaSafe, a handheld optical monitoring device, which supports early detection …
Full company profileInternational Display Advertising Inc financial statements
2025 annualized: Fiscal year 2025 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2025, the balance sheet is the latest quarter. Figures change when the annual report is published.
International Display Advertising Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2007 | 2008 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 Anlz |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | - | - | - | -730K | -3.68M | -4.76M | -4.91M | -1.94M | -1.08M |
| EBITDA | - | - | - | -742K | -3.71M | -4.72M | -4.89M | -1.92M | -1.06M |
| Net Income | - | - | - | -752K | -3.72M | -4.73M | -4.91M | -1.90M | -2.95M |
| EPS | - | - | - | -0.01 | -0.06 | -0.07 | -0.07 | -0.03 | -0.04 |
| Balance Sheet | |||||||||
| Total Assets | - | - | - | 2.09M | 2.94M | 3.29M | 999K | 251K | 175K |
| Total Liabilities | - | - | - | 689K | 572K | 702K | 634K | 545K | 800K |
| Shareholders' Equity | - | - | - | 1.40M | 2.37M | 2.59M | 365K | -294K | -625K |
| Cash & Short-term Investments | - | - | - | 1.87M | 2.82M | 3.00M | 767K | 129K | 63.0K |
| Cash Flow | |||||||||
| Operating Cash Flow | -72.0K | -72.0K | -72.0K | -402K | -2.48M | -3.38M | -3.23M | -1.39M | -362K |
| Capital Expenditure | 0.00 | 31.0K | 31.0K | 31.0K | 31.0K | 50.0K | 2.00K | 0.00 | 0.00 |
| Free Cash Flow | - | - | - | -402K | -2.51M | -3.43M | -3.23M | -1.39M | -362K |
| Ratios | |||||||||
| ROE | - | - | - | -53.7% | -156.7% | -182.6% | -1,344.9% | - | - |
| ROA | - | - | - | -36.0% | -126.3% | -143.7% | -491.4% | -756.6% | -1,684.6% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
International Display Advertising Inc dividends
International Display Advertising Inc has not paid dividends in the last 8 fiscal years.
Last stock split: 1:1000 on Feb 26, 2020.
Who owns International Display Advertising Inc
- Insiders 44.36%
- Institutions 0.00%
- Public & others 55.64%
- Shares outstanding 110M
- Free float 47.1M
International Display Advertising Inc company profile
- Company name
- International Display Advertising Inc
- Ticker
- IRME.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 3
- Fiscal year end
- December
- Address
- ZHR Industrial Zone, Rosh Pinna, Israel, 1231400
- Phone
- 972 4 655 5054
- Website
- ir-medical.com
About International Display Advertising Inc
IR-Med Inc., a medical device company, engages in the development of non-invasive devices for various medical indications. The company's development products pipeline consists of PressureSafe, a handheld skin-agnostic optical monitoring device that supports early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; DiaSafe, a handheld optical monitoring device, which supports early detection of diabetic foot ulcers in lower limb skin and underlying tissue caused by prolonged pressure on the sole of diabetic patients; and Nobiotics, an otoscope to support physicians with an immediate indication as to whether mid-ear, a common malady in children. IR-Med Inc. is headquartered in Rosh Pinna, Israel.
International Display Advertising Inc management
4- Mr. Oded BashanCo-Founder & Chairman · born 1947
- Mr. Aharon KleinCo-Founder, CTO & Director · born 1962
- Dr. Yaniv Cohen M.Sc., Ph.D.Co-Founder, Interim CEO, Chief Scientific Officer & Director · born 1980
- Mr. Sharon LevkovizCFO, Treasurer & Secretary · born 1974